23 May 2013
Keywords: fujisawa, updates, status, pipeline, following, announcement, its
Article | 08 March 2004
Following the announcement of its proposed merger with fellow Japanese firm Yamanouchi (Marketletter March 1), Fujisawa has held an R&D ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 March 2004
© 2013 thepharmaletter.com